Navigation Links
The Neuropathy Association Featured on NBC's 'Today Show' as Part of National Neuropathy Week
Date:5/13/2008

Appearance Aimed To Raise Awareness of Little-Known Neurological Disease That Affects Nearly 20 Million Americans

NEW YORK, May 13 /PRNewswire-USNewswire/ -- Tina Tockarshewsky, executive director at The Neuropathy Association, today called for heightened public awareness and early intervention in the treatment of neuropathy, a potentially painful and often undiagnosed neurological disease that affects upwards of 20 million Americans during an interview with Al Roker on the "Today Show." The Neuropathy Association is a non-profit organization whose mission is to increase public awareness of neuropathy and the need for early intervention and research. Tockarshewsky's appearance was part of the organization's week-long activities to observe National Neuropathy Week (May 12-16), which underscores the toll this disease is taking on Americans' health and quality of life among the general public, healthcare providers, and policymakers.

"While early intervention and treatment can be critical to slowing the disease's progression, most Americans don't recognize neuropathy's symptoms, which include weakness, numbness, tingling and pain, especially in the hands and feet. If ignored, the symptoms can intensify to loss of sensation to unremitting pain. Neuropathy may be the most common disease in the United States that you've never heard of. Many are even unaware that they have it," said Tockarshewsky.

Neuropathy's progression can be variable: some symptoms come on suddenly, some can progress slowly over the years. Some can be mild, and others can be debilitating. However, if diagnosed early, it can often be controlled and some types can be cured. Too often neuropathy is discovered after it has caused irreparable harm.

"Neuropathy affects everyone indiscriminately. With over 100 known types, chances are we all know someone with neuropathy; and yet most of us have never heard of it. The public needs to know the warning signs,
'/>"/>

SOURCE THE NEUROPATHY ASSOCIATION
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
2. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
3. Current and Emerging Therapies Have No Advantage Over Pfizers Lyrica in Their Effect on Patients Quality of Life in the Treatment of Diabetic Neuropathy
4. Yakima Health Care Leader Tapped for Leadership Post at National Association
5. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
6. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
9. Montana Health Care Leader Elected Board Chair of National Association
10. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
11. American Diabetes Association and Goya Foods Inc. Team Up To Support Diabetes Awareness and Outreach in the Latino Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... randomized controlled trials (RCTs) are critical for determining ... Canada provides scant support for these studies compared ... CMAJ ( Canadian Medical Association Journal ... Hamilton Health Sciences, Hamilton, Ontario, with Dr. John ... analysis and appendix that Canada should provide better ...
(Date:5/22/2012)... , , TUESDAY, May 22 (HealthDay News) -- New research ... of snoring and daytime sleepiness, might also cut down ... -- the risk of developing high blood pressure. ... of high blood pressure in two groups with sleep ... CPAP, for either about four or 11 years. CPAP ...
(Date:5/22/2012)... uproar that began last year when the U.S. Preventive ... offer regular prostate-cancer tests to healthy men continued this ... Overall, they stuck to their guns, stating that a ... the PSA test, causes more harm than good ... dangerous, treatments. , But many people simply don,t believe ...
(Date:5/22/2012)... at Barrow Neurological Institute at St. Joseph,s Hospital ... the public perceives some magic tricks in recent ... tactics, marketing and sports. , Susana Martinez-Conde, PhD, ... Macknik, PhD, of Barrow,s Laboratory of Behavioral Neurophysiology ... and illusions. Their most recent original research projects, ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 ... no longer recommends that men routinely undergo prostate ... should ask their doctors for the exam if ... Urologists and cancer experts dismissed the idea that ... the PSA test will set a man,s personal ...
Breaking Medicine News(10 mins):Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Psychological Science explains uproar over prostate-cancer screenings 2Health News:Barrow researchers use magic for discoveries 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 3
... scientists and clinicians to present advances,in CF research and ... meeting will draw more than 3,000 cystic fibrosis experts ... 3 - 6, 2007 to present the,latest information and ... The 21st annual North American Cystic Fibrosis Conference is ...
... Bristol-Myers Squibb,(NYSE: BMY ) announced today that ... Development organization as senior vice president, External,Science, Technology ... Sigal,chief scientific officer and president, Research and Development. ... R&D organization at this critical,juncture for Bristol-Myers Squibb, ...
... leading cause of parasitic infections in U.S. , THURSDAY, ... genome of the intestinal parasite Giardia lamblia , ... in the United States. , That makes giardia the ... in the country, experts note. , People contract Giardia ...
... the United States have determined that young adolescents who see ... To combat smoking among youth, public health groups have called ... A new study from New Zealand, however, calls that strategy ... the intended effect of putting such movies out of reach ...
... ... Executives to Provide Leadership, CHICAGO, Sept. 27 ... investment firms, has established an,Advisory Board to provide unbiased ... business partnerships. John H. Driscoll,Alter+Care President, announced the Alter+Care ...
... Complicated daily regimens lower their quality of life, ... For some people with diabetes, the burden of adhering ... their diabetes-related health complications, a U.S. study finds. , ... 700 adults with type 2 diabetes. , As reported ...
Other Medicine News:Health News:Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting 2Health News:Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing 2Health News:Scientists Map Intestinal Bug's Genome 2Health News:R rating might be unlikely to affect teens exposure to smoking in movies 2Health News:Alter+Care Creates the Advisory Board 2Health News:Alter+Care Creates the Advisory Board 3Health News:For Some, Diabetes Care Worse Than Illness Itself 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... 24, 2007 - ImmunoGen, Inc.,(Nasdaq: IMGN), a biopharmaceutical ... Prodrug (TAP),technology, today announced that clinical findings for ... tumors are to be,reported at the 43rd American ... place June 1-5, 2007 in Chicago, IL., Trastuzumab-DM1 ...
... 2007 /PRNewswire/ -- With enormous,investments and the ... firms need to develop effective strategies for,communicating ... communication planning and execution will gain a ... research and consulting firm Best Practices, LLC,successful ...
Other Medicine Technology:ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 2Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 3
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: